Status: Recruiting
Study on c-Met Targeted PET/CT Imaging in NSCLC
The investigators developed a 18F labeled small molecule, 18F-TSPF, based on c-Met TKI, as a targeted molecular imaging agent for noninvasive and repeatable detecting c-Met activation status.
Participants needed: 88
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Xilin SunUpdated: Apr 4, 2025Locations: 1
Eligibility criteria
Age range 18-75 years, open to both male and female participants; [+7]
Severe abnormalities in liver and renal function and blood counts; [+6]